These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 21042751)
1. Telomerase suppression initiates PML-dependent p53 activation to inhibit bladder cancer cell growth. Xue Y; Li L; Zhang D; Wu K; Guo P; Zeng J; Wang X; He D Oncol Rep; 2010 Dec; 24(6):1551-9. PubMed ID: 21042751 [TBL] [Abstract][Full Text] [Related]
2. p53 and p21(Waf1) are recruited to distinct PML-containing nuclear foci in irradiated and Nutlin-3a-treated U2OS cells. Shen H; Maki CG J Cell Biochem; 2010 Dec; 111(5):1280-90. PubMed ID: 20803550 [TBL] [Abstract][Full Text] [Related]
3. AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation. Li Q; He Y; Wei L; Wu X; Wu D; Lin S; Wang Z; Ye Z; Lin SC Oncogene; 2011 Mar; 30(10):1194-204. PubMed ID: 21057547 [TBL] [Abstract][Full Text] [Related]
4. Promyelocytic leukemia protein is required for gain of function by mutant p53. Haupt S; di Agostino S; Mizrahi I; Alsheich-Bartok O; Voorhoeve M; Damalas A; Blandino G; Haupt Y Cancer Res; 2009 Jun; 69(11):4818-26. PubMed ID: 19487292 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of PML induced apoptosis in bladder cancer cell by caspase dependent pathway. Li L; He D; He H; Wang X; Zhang L; Luo Y; Nan X Cancer Lett; 2006 May; 236(2):259-68. PubMed ID: 16216409 [TBL] [Abstract][Full Text] [Related]
6. PML-IV functions as a negative regulator of telomerase by interacting with TERT. Oh W; Ghim J; Lee EW; Yang MR; Kim ET; Ahn JH; Song J J Cell Sci; 2009 Aug; 122(Pt 15):2613-22. PubMed ID: 19567472 [TBL] [Abstract][Full Text] [Related]
7. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7. Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989 [TBL] [Abstract][Full Text] [Related]
8. The Pinx1 Gene Downregulates Telomerase and Inhibits Proliferation of CD133+ Cancer Stem Cells Isolated from a Nasopharyngeal Carcinoma Cell Line by Regulating Trfs and Mad1/C-Myc/p53 Pathways. Shen C; Chen F; Wang H; Li G; Yu C; Wang X; Wen Z Cell Physiol Biochem; 2018; 49(1):282-294. PubMed ID: 30138944 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of the promyelocytic leukemia gene suppresses growth of human bladder cancer cells by inducing G1 cell cycle arrest and apoptosis. He D; Nan X; Chang KS; Wang Y; Chung LW Chin Med J (Engl); 2003 Sep; 116(9):1394-8. PubMed ID: 14527374 [TBL] [Abstract][Full Text] [Related]
10. Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription and telomerase activity. Zou L; Zhang P; Luo C; Tu Z Urology; 2006 Jun; 67(6):1335-40. PubMed ID: 16765199 [TBL] [Abstract][Full Text] [Related]
11. Relief of p53-mediated telomerase suppression by p73. Toh WH; Kyo S; Sabapathy K J Biol Chem; 2005 Apr; 280(17):17329-38. PubMed ID: 15734740 [TBL] [Abstract][Full Text] [Related]
12. Growth arrest in ovarian cancer cells by hTERT inhibition short-hairpin RNA targeting human telomerase reverse transcriptase induces immediate growth inhibition but not necessarily induces apoptosis in ovarian cancer cells. Luo Y; Yi Y; Yao Z Cancer Invest; 2009 Dec; 27(10):960-70. PubMed ID: 19909010 [TBL] [Abstract][Full Text] [Related]
13. shRNA-targeted hTERT suppress cell proliferation of bladder cancer by inhibiting telomerase activity. Zou L; Zhang P; Luo C; Tu Z Cancer Chemother Pharmacol; 2006 Feb; 57(3):328-34. PubMed ID: 16028098 [TBL] [Abstract][Full Text] [Related]
14. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells. Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437 [TBL] [Abstract][Full Text] [Related]
15. A CK2-dependent mechanism for degradation of the PML tumor suppressor. Scaglioni PP; Yung TM; Cai LF; Erdjument-Bromage H; Kaufman AJ; Singh B; Teruya-Feldstein J; Tempst P; Pandolfi PP Cell; 2006 Jul; 126(2):269-83. PubMed ID: 16873060 [TBL] [Abstract][Full Text] [Related]
16. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells. Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139 [TBL] [Abstract][Full Text] [Related]
17. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191 [TBL] [Abstract][Full Text] [Related]
18. Twisted epithelial-to-mesenchymal transition promotes progression of surviving bladder cancer T24 cells with hTERT-dysfunction. Xue Y; Li L; Zhang D; Wu K; Chen Y; Zeng J; Wang X; He D PLoS One; 2011; 6(11):e27748. PubMed ID: 22110753 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells. Herzer K; Weyer S; Krammer PH; Galle PR; Hofmann TG Cancer Res; 2005 Dec; 65(23):10830-7. PubMed ID: 16322229 [TBL] [Abstract][Full Text] [Related]
20. The key role of PML in IFN-α induced cellular senescence of human mesenchymal stromal cells. Fu S; Wei J; Wang G; Wang B; Wang Y; Lai X; Huang H Int J Oncol; 2015 Jan; 46(1):351-9. PubMed ID: 25354534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]